ETFs Holding BTX »    BTX Historical Stock Prices »
BTX News Video: Mon, Nov 28, 2016, 1:01 PM — Monday Sector Laggards: Biotechnology, Music & Electronics Stores

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioTime is a clinical-stage biotechnology company targeting degenerative diseases. Co.'s programs are based on two main proprietary technology platforms: cell replacement and cell/drug delivery. With its cell replacement platform, Co. is creating new cells and tissues with its pluripotent and progenitor cell technologies. These cells and tissues are developed to replace those that are either rendered dysfunctional or lost due to degenerative diseases. Co.'s cell/drug delivery programs are based upon its proprietary HyStem® cell and drug delivery matrix technology. HyStem® is designed to provide for the transfer, retention, engraftment and metabolic support of cellular replacement therapy. Self directed investors in BioTime Inc will be interested in keeping up with all BioTime Inc news they can find, both BTX news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on BTX. At RediNews, we simplify this task by presenting both BTX news releases originating from BioTime Inc itself, and BTX news from a variety of media outlets. Visitors can browse this news online and through our BTX RSS news feed.

BTX News

BTX News — Articles, Videos, & Press Releases

Top Ranked Momentum Stocks to Buy for April 2nd
Tuesday, April 2, 2019, 8:38 AM — Zacks
Short Interest Drops 11.3% For BTX
Tuesday, February 12, 2019, 2:45 PM — Market News Video
Commit To Buy BioTime At $1, Earn 22.4% Annualized Using Options
Wednesday, January 9, 2019, 11:20 AM — Stock Options Channel
Short Sellers Drawn To These Five Jim Simons Holdings
Monday, November 12, 2018, 11:13 AM — Dividend Channel
The Math Shows EES Can Go To $43
Tuesday, November 6, 2018, 8:01 AM — ETF Channel
Commit To Purchase BioTime At $2, Earn 24.6% Annualized Using Options
Monday, October 8, 2018, 11:53 AM — Stock Options Channel
Russell 2000 Headed 12% Higher, If Analysts Got The Components Right
Tuesday, September 25, 2018, 7:24 AM — ETF Channel
Short Interest In BioTime Moves 10% Higher
Monday, August 27, 2018, 11:42 AM — Market News Video
Peek Under The Hood: EQWS Has 13% Upside
Thursday, August 23, 2018, 7:58 AM — ETF Channel
How The Parts Add Up: IWV Headed For $183
Monday, July 23, 2018, 8:55 AM — ETF Channel
How The Parts Add Up: SPTM Headed For $38
Thursday, June 21, 2018, 8:12 AM — ETF Channel
Commit To Purchase BioTime At $2, Earn 14.9% Annualized Using Options
Wednesday, June 20, 2018, 11:49 AM — Stock Options Channel
Short Sellers Drawn To These Five Jim Simons Holdings
Tuesday, June 12, 2018, 1:47 PM — Dividend Channel
BTX is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


The best thing about dynamic market content like our RediNews RSS feeds is it constantly changes, giving your users a reason to keep coming back. Even if you have never worked with XML stock data before, you'll find our RSS feeds simple to integrate because they follow the Really Simple Syndication (RSS) standard. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . Seldom is free web content of such high quality and usefulness as our feeds, so give them a try and let RediNews be your financial content provider of choice for news headlines either within your existing web page content or create a new stock content section to add to your current web site offerings. Remember, our RSS feeds are absolutely free, so unlike some other types of content requiring a costly stock data content license, we charge nothing for this dynamic web content.

BTX News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.